Zealand Pharma Targets Next-Generation Weight Loss

This is a news story, published by CNBC, that relates primarily to Zealand Pharma news.

Zealand Pharma news

For more Zealand Pharma news, you can click here:

more Zealand Pharma news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

CNBC news

For more news from CNBC, you can click here:

more news from CNBC

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

Danish biotech Zealand Pharma

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Zealand Pharma news, global pharma firm news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

separate obesity drug candidate

CNBC

•

Health

Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says

Summary

Nutrition label

81% Informative

Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs.

CEO Adam Steensberg heralded early-stage trial results of its GLP-1 treatment in an interview with CNBC .

He said it's the company's separate obesity drug candidate, Petrelintide , that sets it apart.

Zealand Pharma CEO: "It's not something Zealand could even think about, manufacturing themselves" Steensberg ruled out growing speculation around a takeover, saying it's "definitely not part of our plans" But he noted that even with a significant $1 billion capital raise earlier this year , the company would need a partner.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful